• • About CBHO
  • About SCCA
  • Accomplishments
  • Community Involvement
  • FAQ
  • Privacy Policy
  • Disclaimer
• • Thomas Rado - MD, PhD
  • Arun Patel - MD
  • Basir Haque - MD
  • Iyad Hamarneh - MD
  • Soumya Donohoe - MSN, ARNP, AOCNP
  • Marlene SanFilippo - MSN, ARNP
  • Mitra Rado - MN, ARNP, AOCNP
  • Lynne Allen - MN, ARNP
  • Eric Gamboa - MD
• • Clinical Trials
  • Available Trials
• • Appointments
  • Patient Forms
  • Treatments/Procedures
  • Collaboration
  • Insurance Information
  • Prescriptions/Refills
  • Support Services
  • Testimonials
• • Contact Us
  • Referrals
  • Links
  • Clinicians Resource
  • FAQ

Our collaboration with the Seattle Cancer Care Alliance And Fred Hutchinson Research Give our patients more treatment options.

CBHO Research Department
7360 W. Deschutes Ave.
Kennewick, WA 99336
(509)783-4637
research@cbho.org

Clinical Trials

Groundbreaking clinical trials today for our patient's future tomorrow.

As we move toward the future, our goals re-main unchanged: To provide evidence-based treatment and powerful research protocols for our patients in an atmosphere of caring and joy.

What is a clinical trial?

New treatments have to be proven as safe as well as effective prior to being available to a large number of patients. These new treatments are tested through clinical trials using a limited number of patients.

Why participate in a clinical trial?

Patients that enroll in clinical trials have the opportunity to access new treatments before they are widely available as well as contribute to the advancement of cancer treatment.

What happens when you are in a clinical trial?

The patient would be followed by your physician and the research team from the beginning by getting a check up prior to starting the study, be monitored during the trial, and have continued contact with the research department after they are off study treatment.

What are "phases" of clinical trials?

Phase I trials: Studies of an experimental drug or treatment that are conducted in a small group of patients (20-80) for the first time to evaluate the safety of the drug, find out the safe dose range as well as a side effect profile

Phase II trials: Studies of an experimental drug or treatment that is given to a larger group of patients (100-300) to see if it is effective as well as continue to evaluate safety.

Phase III trials: Studies of an experimental drug or treatment that is given to large groups of patients (1,000-3,000) to confirm effectiveness, continue to monitor side effects, compare to standard treatments.

Phase IV trials: Studies conducted after the experimental drug is commercially available and clarify additional drug information including risks, benefits and optimal use.

Can a patient leave a clinical trial after they have enrolled?

Yes. A patient can decide to stop participating in a clinical trial at any time.

How do I become eligible for a clinical trial?

Not everyone qualifies for a clinical trial. If you are curious about what you may qualify for, ask your doctor. You can also contact our research department to review your options.

Does my insurance cover clinical trials?

This varies. We communicate with the insurance company prior to enrolling any patient onto a clinical trial to receive a prior authorization.

Click here to see all available trials